To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
99pct
497d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2009 · fourth_quarter · Health Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $330,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Client expense: $330,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Client expense: $570,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Client expense: $550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Health Issues
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
Client expense: $600,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Food Industry (safety, labeling, etc.)
H.R. 759 Food & Drug Administration Globalization Act of 2009; H.R. 815/S. 425 Safe and Fair Enforcement and Food Act of 2009; H.R. 875 Food Safety Modernization Act of 2009; H.R. 994 Keeping America's Food Safe Act of 2009; H.R. 1332 Safe Food Enforcement, Assessment Standards and Targeting Act of 2009; S. 429 Ending Agricultural Threats: Safeguarding America's Food for Everyone Act of 2009; S. 510 FDA Food Safety Modernization Act of 2009 H.R. 1907 Improving Communications with Consumers During Food Recall Act of 2009 H.R. 841 Protecting Consumers Act of 2009
Client expense: $1,131,806 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2007 · year_end · Financial Institutions/Investments/Securities
HR705, S880, S836, HR1103, HR1744, S10, HR759, S386, S388, S387, S745, S1151, HR995, S342, S129, HR325, S732, S2614 Fair and Accurate Credit Transactions Act, ILCs, Pay Day Lending
Client expense: $3,562,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2007 · mid_year · Financial Institutions/Investments/Securities
HR705, S880, S836, HR1103, HR1744, S10, HR759, S386, S388, S387, S745, S1151, HR995, S342, S129, HR325, S732, S2614 Fair and Accurate Credit Transactions Act, ILCs, Pay Day Lending
Client expense: $3,562,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2007 · mid_year · Financial Institutions/Investments/Securities
HR705, S880, S836, HR1103, HR1744, S10, HR759, S386, S388, S387, S745, S1151, HR995, S342, S129, HR325, S732, S2614 Fair and Accurate Credit Transactions Act, ILCs
Client expense: $3,562,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
| Republican |
| CA |
| Frank R. Wolf | Republican | VA |
| Gregory W. Meeks | Democratic | NY |
| Henry A. Waxman | Democratic | CA |
| Jeff Miller | Republican | FL |
| Jerrold Nadler | Democratic | NY |
| John Kuhl | Republican | NY |
| José E. Serrano | Democratic | NY |
| Steve Cohen | Democratic | TN |